SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001346302-19-000002
Filing Date
2019-01-22
Accepted
2019-01-22 16:07:15
Documents
1
Period of Report
2019-01-22
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K a8-kfederalforumprovision.htm 8-K 41200
  Complete submission text file 0001346302-19-000002.txt   42256
Mailing Address 180 NORTH LASALLE STREET STE 1800 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET STE 1800 CHICAGO IL 60601 512-498-2670
XERIS PHARMACEUTICALS INC (Filer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38536 | Film No.: 19535465
SIC: 2834 Pharmaceutical Preparations